Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 42,876 | 9,514 | 486 | 0 | 1,028 |
| Gross Profit | 42,876 | 9,514 | 486 | N/A | 1,028 |
| Operating Expenses | 47,528 | 57,221 | 79,206 | 60,533 | 46,463 |
| Operating Income | -4,652 | -47,707 | -78,720 | -60,533 | -45,435 |
| Interest Expense | 1,632 | 467 | 935 | 1,003 | 778 |
| Other Income | 4,803 | -7,891 | 2,614 | 5,626 | 2,687 |
| Pre-tax Income | -1,481 | -56,065 | -77,041 | -55,910 | -43,526 |
| Net Income Continuous | -1,481 | -56,065 | -77,041 | -55,910 | -43,526 |
| Minority Interests | N/A | 47,579 | -18,591 | -10,791 | -1,720 |
| Net Income | $-1,481 | $-103,644 | $-58,450 | $-45,119 | $-41,806 |
| EPS Basic Total Ops | -0.27 | -26.80 | -18.10 | -15.80 | -21.30 |
| EPS Basic Continuous Ops | -0.27 | -14.52 | -23.85 | -19.55 | -22.23 |
| EPS Diluted Total Ops | -0.27 | -26.80 | -18.10 | -15.80 | -21.30 |
| EPS Diluted Continuous Ops | -0.27 | -14.52 | -23.85 | -19.55 | -22.23 |
| EPS Diluted Before Non-Recurring Items | 0.20 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $384 | $-42,702 | $-74,185 | $-57,397 | $-42,758 |